AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32051193 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating arachidonic acid
Number of subjects: 24000
Study 32051193 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating eicosapentaenoic acid
Number of subjects: 24000
Study 32051193 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating docosapentaenoic acid
Number of subjects: 24000
Study 35032651 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased SpO2 targets in hospitals (14 hospitals)
Number of subjects: 8142
Study 35032651 — intervention group
Group type: COMPARATOR
Intervention: No change in SpO2 targets in hospitals (7 hospitals)
Number of subjects: 8142
Study 33813982 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based Multi-Sensory Program (MSP)
Number of subjects: 0
Study 33813982 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32889135 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese acupuncture
Number of subjects: 0
Study 32889135 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 0
Study 32889135 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 0
Study 37468607 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Training
Number of subjects: 0
Study 34886078 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-myofascial release (SMR) applied to the posterior part of the sural fascia for 10 min
Number of subjects: 94
Study 34886078 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-myofascial release (SMR) applied to the posterior part of the crural fascia for 10 min
Number of subjects: 94
Study 34886078 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-myofascial release (SMR) applied to any of the SBL segments for 10 min
Number of subjects: 94
Study 36351989 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee-powered lower limb exoskeleton (ABLE Exoskeleton)
Number of subjects: 10
Study 36351989 — intervention group
Group type: COMPARATOR
Intervention: Passive orthoses (KAFOs)
Number of subjects: 10
Study 32706061 — intervention group
Group type: EXPERIMENTAL
Intervention: Major Trauma Clinical Pathway (MTCP) monitoring system
Number of subjects: 998240
Study 36217135 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health application (8-week intervention)
Number of subjects: 130
Study 36217135 — intervention group
Group type: COMPARATOR
Intervention: Waiting control group (no intervention)
Number of subjects: 130
Study 33405987 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital interactive multimedia tutorial (DIMT; 45-minute narrated, interactive module)
Number of subjects: 42
Study 33405987 — intervention group
Group type: COMPARATOR
Intervention: Lecture (45-minute lecture by a faculty member)
Number of subjects: 42
Study 33405987 — intervention group
Group type: COMPARATOR
Intervention: Independent study (45 minutes to read a highlighted textbook chapter)
Number of subjects: 42
Study 32028859 — intervention group
Group type: EXPERIMENTAL
Intervention: AFT/FIS workshop
Number of subjects: 58
Study 32028859 — intervention group
Group type: COMPARATOR
Intervention: Demonstration training (DT) workshop
Number of subjects: 58
Study 34776422 — intervention group
Group type: EXPERIMENTAL
Intervention: 10Hz frequency rTMS
Number of subjects: 90
Study 34776422 — intervention group
Group type: EXPERIMENTAL
Intervention: 5Hz frequency rTMS
Number of subjects: 90
Study 34776422 — intervention group
Group type: EXPERIMENTAL
Intervention: 1Hz frequency rTMS
Number of subjects: 90
Study 34776422 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy persons)
Number of subjects: 90
Study 33023877 — intervention group
Group type: EXPERIMENTAL
Intervention: TCPRLink
Number of subjects: 186
Study 33023877 — intervention group
Group type: COMPARATOR
Intervention: T-CPR
Number of subjects: 186
Study 34350594 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital Bodies intervention
Number of subjects: 290
Study 34350594 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 290
Study 33887308 — intervention group
Group type: EXPERIMENTAL
Intervention: Foraminal enlargement (FE)
Number of subjects: 140
Study 34666302 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) 400 mg three times a day for 10 days
Number of subjects: 72
Study 34666302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 34666302 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX)
Number of subjects: 72
Study 34666302 — intervention group
Group type: COMPARATOR
Intervention: Pentoxifylline (PTX) and Placebo
Number of subjects: 72
Study 33600687 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled Human Insulin (Exubera®)
Number of subjects: 121
Study 33600687 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous Insulin
Number of subjects: 121
Study 34311704 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized clinical trials (RCTs)
Number of subjects: 392
Study 33075257 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose 24-hour infusion of tranexamic acid
Number of subjects: 0
Study 33075257 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35356803 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat (F group)
Number of subjects: 21
Study 35356803 — intervention group
Group type: COMPARATOR
Intervention: Benzbromarone (B group)
Number of subjects: 21
Study 35201829 — intervention group
Group type: EXPERIMENTAL
Intervention: Illegal tobacco purchases with fines (ITP_F)
Number of subjects: 93
Study 35201829 — intervention group
Group type: EXPERIMENTAL
Intervention: Illegal tobacco purchases with fines, criminal record, and negative public exposure (ITP_F + CR + NPE)
Number of subjects: 93
Study 35201829 — intervention group
Group type: COMPARATOR
Intervention: Legal tobacco purchases (LTP)
Number of subjects: 93
Study 33536398 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemafibrate 0.025-0.2 mg BID
Number of subjects: 212
Study 33536398 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate 100 mg QD
Number of subjects: 212
Study 33536398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study 32419119 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting intervention integrated with primary health care, including a parenting pamphlet and two parenting training sessions
Number of subjects: 168
Study 34665865 — intervention group
Group type: EXPERIMENTAL
Intervention: LD-RTX plus ATRA
Number of subjects: 168
Study 34665865 — intervention group
Group type: COMPARATOR
Intervention: LD-RTX monotherapy
Number of subjects: 168
Study 33107490 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 22
Study 33107490 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 22
Study 33829894 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive Health Education (CHE)
Number of subjects: 428
Study 33829894 — intervention group
Group type: COMPARATOR
Intervention: Standard Health Education (SHE)
Number of subjects: 428
Study 33641504 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise program over 9 weeks
Number of subjects: 26
Study 33641504 — intervention group
Group type: COMPARATOR
Intervention: No-exercise group
Number of subjects: 26
Study 32961848 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AE) for 6 months
Number of subjects: 26
Study 32961848 — intervention group
Group type: COMPARATOR
Intervention: Passive control group (CG)
Number of subjects: 26
Study 36333954 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic Acid (5-mg intravenously)
Number of subjects: 76
Study 34187126 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil massage for lower back and lower leg during hemodialysis for eight weeks
Number of subjects: 200
Study 34187126 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 200
Study 34187126 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil massage
Number of subjects: 200
Study 33595792 — intervention group
Group type: EXPERIMENTAL
Intervention: Amikacin liposome inhalation suspension (ALIS) 590 mg once daily
Number of subjects: 53
Study 33555430 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative intestinal isolation bag
Number of subjects: 92
Study 33555430 — intervention group
Group type: COMPARATOR
Intervention: Standard care (no isolation bag)
Number of subjects: 92
Study 33789646 — intervention group
Group type: EXPERIMENTAL
Intervention: Perio Slim (PS) scaler tip
Number of subjects: 30
Study 33789646 — intervention group
Group type: COMPARATOR
Intervention: Conventional scaler tip
Number of subjects: 30
Study 33499025 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g β-Lactoglobulin (BLG)
Number of subjects: 16
Study 33499025 — intervention group
Group type: COMPARATOR
Intervention: 25 g Whey Protein Isolate (WPI)
Number of subjects: 16
Study 32517498 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise program
Number of subjects: 64
Study 32517498 — intervention group
Group type: COMPARATOR
Intervention: Non-supervised exercise program
Number of subjects: 64
Study 34895854 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anaesthetic (chirocaine)
Number of subjects: 20
Study 34895854 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 20
Study 34105063 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular paromomycin monotherapy (20 mg/kg for 21 days) in African patients
Number of subjects: 602
Study 34105063 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular paromomycin monotherapy (15 mg/kg for 21 days) in Indian patients
Number of subjects: 602
Study 34105063 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (15 mg/kg for 17 days with sodium stibogluconate) in African patients
Number of subjects: 602
Study 36037051 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication intervention using a 5-step framework
Number of subjects: 47
Study 36037051 — intervention group
Group type: COMPARATOR
Intervention: Pain management recommendations from the CDC (Control)
Number of subjects: 47
Study 32628771 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflectance confocal microscopy (RCM)
Number of subjects: 0
Study 32628771 — intervention group
Group type: COMPARATOR
Intervention: Punch biopsy (PB)
Number of subjects: 0
Study 32628771 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient satisfaction and preferences
Number of subjects: 0
Study 35978380 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional shoulder musculoskeletal rehabilitation combined with aerobic exercises
Number of subjects: 0
Study 35978380 — intervention group
Group type: COMPARATOR
Intervention: Solely conventional shoulder musculoskeletal rehabilitation
Number of subjects: 0
Study 33947690 — intervention group
Group type: EXPERIMENTAL
Intervention: Veliparib throughout (240 mg BID for 14 days, then 400 mg BID maintenance)
Number of subjects: 181
Study 33947690 — intervention group
Group type: EXPERIMENTAL
Intervention: Veliparib combination only (240 mg BID for 14 days, then placebo)
Number of subjects: 181
Study 33947690 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo plus chemotherapy followed by placebo)
Number of subjects: 181
Study 33947690 — intervention group
Group type: EXPERIMENTAL
Intervention: Veliparib throughout in SLFN11-positive patients
Number of subjects: 181
Study 33947690 — intervention group
Group type: EXPERIMENTAL
Intervention: Veliparib throughout
Number of subjects: 181
Study 33947690 — intervention group
Group type: EXPERIMENTAL
Intervention: Veliparib combination only
Number of subjects: 181
Study 33947690 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 181
Study 32436159 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral scanner (group IS)
Number of subjects: 690
Study 32436159 — intervention group
Group type: COMPARATOR
Intervention: Control group (plaster casts digitized by a laboratory scanner, group ID)
Number of subjects: 690
Study 35027302 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy with inhaled lavender essential oil (n = 30)
Number of subjects: 90
Study 35027302 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing exercises (n = 30)
Number of subjects: 90
Study 35027302 — intervention group
Group type: COMPARATOR
Intervention: Routine care (n = 30)
Number of subjects: 90
Study 32031665 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab 80mg every 2 weeks (IXEQ2W)
Number of subjects: 417
Study 32031665 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab 80mg every 4 weeks (IXEQ4W)
Number of subjects: 417
Study 32031665 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab 40mg every 2 weeks (ADA)
Number of subjects: 417
Study 32031665 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 417
Study 32584996 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate for 48 weeks
Number of subjects: 0
Study 32584996 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate for an additional 48 weeks
Number of subjects: 0
Study 32584996 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate after stopping treatment
Number of subjects: 0
Study 32584996 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32314290 — intervention group
Group type: EXPERIMENTAL
Intervention: Zataria multiflora extract 10 mg/kg/day (Z10)
Number of subjects: 34
Study 32314290 — intervention group
Group type: EXPERIMENTAL
Intervention: Zataria multiflora extract 5 mg/kg/day (Z5)
Number of subjects: 34
Study 32314290 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 35836222 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week online intervention on healthy nutrition, physical activity, and wellbeing behaviours
Number of subjects: 2240
Study 35836222 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster sessions delivered during one class session in Grades 8 and 9
Number of subjects: 2240
Study 33566107 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine
Number of subjects: 427
Study 33566107 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 427
Study 33310163 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin augmentation
Number of subjects: 60
Study 33310163 — intervention group
Group type: EXPERIMENTAL
Intervention: Delay in initiating oxytocin
Number of subjects: 60
Study 33310163 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision to deliver by CS
Number of subjects: 60
Study 33310163 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to delivery after CS decision
Number of subjects: 60
Study 33310163 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-partum hemorrhage
Number of subjects: 60
Study 33310163 — intervention group
Group type: EXPERIMENTAL
Intervention: Chorioamnionitis
Number of subjects: 60
Study 33310163 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical injury during intrapartum CS
Number of subjects: 60
Study 33310163 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-partum complications
Number of subjects: 60
Study 34753185 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroxine therapy
Number of subjects: 112
Study 34753185 — intervention group
Group type: COMPARATOR
Intervention: HDP exposure
Number of subjects: 112
Study 34753185 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 112
Study 36474755 — intervention group
Group type: EXPERIMENTAL
Intervention: EP-104IAR (15 mg)
Number of subjects: 32
Study 36474755 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 32
Study 35120193 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% oxygen
Number of subjects: 600
Study 35120193 — intervention group
Group type: COMPARATOR
Intervention: 30% oxygen
Number of subjects: 600
Study 35120193 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidants (3 g IV vitamin C and 100 mg/kg N‐acetylcysteine)
Number of subjects: 600
Study 35120193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 600
Study 35120193 — intervention group
Group type: COMPARATOR
Intervention: Mortality at 30 days (80% vs. 30% oxygen)
Number of subjects: 600
Study 35120193 — intervention group
Group type: COMPARATOR
Intervention: Mortality at 30 days (antioxidants vs. placebo)
Number of subjects: 600
Study 33547997 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-fluidics system
Number of subjects: 50
Study 33547997 — intervention group
Group type: COMPARATOR
Intervention: Gravity-fluidics system
Number of subjects: 50
Study 32406210 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT), 8.3 ± 2 sessions
Number of subjects: 37
Study 32406210 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline symptom severity
Number of subjects: 37
Study 34480886 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient Rehabilitation Facilities (IRFs)
Number of subjects: 400000
Study 34480886 — intervention group
Group type: COMPARATOR
Intervention: Skilled Nursing Facilities (SNFs)
Number of subjects: 400000
Study 34089920 — intervention group
Group type: EXPERIMENTAL
Intervention: Tangle
Number of subjects: 271
Study 34089920 — intervention group
Group type: EXPERIMENTAL
Intervention: Wobble cushion
Number of subjects: 271
Study 34089920 — intervention group
Group type: EXPERIMENTAL
Intervention: Earmuffs
Number of subjects: 271
Study 34089920 — intervention group
Group type: COMPARATOR
Intervention: Nothing (control condition)
Number of subjects: 271
Study 33006193 — intervention group
Group type: EXPERIMENTAL
Intervention: Multigrain flatbread
Number of subjects: 100
Study 33006193 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 34985503 — intervention group
Group type: EXPERIMENTAL
Intervention: OCS Liver
Number of subjects: 300
Study 34632601 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-collected HPV testing
Number of subjects: 0
Study 34632601 — intervention group
Group type: COMPARATOR
Intervention: Provider-collected HPV testing
Number of subjects: 0
Study 35316091 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral parent training intervention
Number of subjects: 0
Study 35316091 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study 35655149 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week group CBT program (N = 50)
Number of subjects: 100
Study 35655149 — intervention group
Group type: COMPARATOR
Intervention: Non-CBT control condition (N = 50)
Number of subjects: 100
Study 32412700 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine 84 mg nasal spray twice-weekly for 4 weeks + standard-of-care treatment
Number of subjects: 226
Study 32412700 — intervention group
Group type: COMPARATOR
Intervention: Placebo nasal spray twice-weekly for 4 weeks + standard-of-care treatment
Number of subjects: 226
Study 35085482 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal indometacin (100 mg) administered 30 min before ESWL
Number of subjects: 1370
Study 35085482 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical glycerin suppositories) administered 30 min before ESWL
Number of subjects: 1370
Study 35085482 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal indometacin (100 mg)
Number of subjects: 1370
Study 35085482 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical glycerin suppositories)
Number of subjects: 1370
Study 33670353 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Lifestyle Program
Number of subjects: 164
Study 33670353 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Affect Promotion Program
Number of subjects: 164
Study 33670353 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Program
Number of subjects: 164
Study 36059913 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified pouch technique (n: 8)
Number of subjects: 16
Study 36059913 — intervention group
Group type: COMPARATOR
Intervention: Pouch technique (n: 8)
Number of subjects: 16
Study 32381496 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC) at 3 L·kg‐1·min‐1
Number of subjects: 268
Study 32381496 — intervention group
Group type: COMPARATOR
Intervention: Standard oxygen therapy (Control)
Number of subjects: 268
Study 32381496 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC)
Number of subjects: 268
Study 35598164 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent diabetes self‐efficacy
Number of subjects: 157
Study 35598164 — intervention group
Group type: COMPARATOR
Intervention: Clinically elevated depressive symptoms and stress
Number of subjects: 157
Study 33888900 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 µg BNT162b1
Number of subjects: 144
Study 33888900 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 µg BNT162b1
Number of subjects: 144
Study 33888900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study 35092241 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary approach to treatment
Number of subjects: 36
Study 35092241 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy regimen
Number of subjects: 36
Study 34813489 — intervention group
Group type: EXPERIMENTAL
Intervention: Videoconference-based cognitive behavioral therapy (vCBT)
Number of subjects: 30
Study 34813489 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 30
Study 35318567 — intervention group
Group type: EXPERIMENTAL
Intervention: Gas Man® simulation using patient weight and the same FGF, vaporizer and minute ventilation settings
Number of subjects: 28
Study 33537850 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimanual vitrectomy with chandelier illumination, perfluorocarbon liquid (PFCL), and vital dyes.
Number of subjects: 36
Study 33537850 — intervention group
Group type: COMPARATOR
Intervention: Bimanual vitrectomy with chandelier illumination only.
Number of subjects: 36
Study 33537850 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimanual vitrectomy
Number of subjects: 36
Study 33537850 — intervention group
Group type: COMPARATOR
Intervention: Bimanual vitrectomy
Number of subjects: 36
Study 32678767 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior wedge
Number of subjects: 30
Study 32678767 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior-medial wedge
Number of subjects: 30
Study 32678767 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral wedge
Number of subjects: 30